Carlsmed, Inc. Increase (Decrease) in Accrued Liabilities
Carlsmed, Inc. (CARL) reported Increase (Decrease) in Accrued Liabilities of $848.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-05
- Carlsmed, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $922.00K.
- Carlsmed, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$74.00K, a 115.61% decline year-over-year.
- Carlsmed, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $97.00K, a 84.94% decline year-over-year.
- Carlsmed, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $608.00K, a 394.31% increase year-over-year.
- Carlsmed, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $627.00K, a 48.10% decline from fiscal 2024.
- Carlsmed, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $1.21M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $922.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $848.00K 10-Q · filed 2026-08-05 | $945.00K derived: sum of 3 quarters · filed 2026-08-05 | $1.55M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$74.00K 10-Q · filed 2026-05-05 | $23.00K derived: sum of 2 quarters · filed 2026-05-05 | $631.00K derived: sum of 3 quarters · filed 2026-05-05 | $79.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $97.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $705.00K derived: sum of 2 quarters · filed 2026-02-25 | $153.00K derived: sum of 3 quarters · filed 2026-08-05 | $627.00K 10-K · filed 2026-02-25 |
| 2025-09-30 | $608.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $56.00K derived: sum of 2 quarters · filed 2026-08-05 | $530.00K 10-Q · filed 2025-11-06 | $1.17M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$552.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$78.00K 10-Q · filed 2026-08-05 | $566.00K derived: sum of 3 quarters · filed 2026-08-05 | $689.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $474.00K 10-Q · filed 2026-05-05 | $1.12M derived: sum of 2 quarters · filed 2026-05-05 | $1.24M derived: sum of 3 quarters · filed 2026-05-05 | |
| 2024-12-31 | $644.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $767.00K derived: sum of 2 quarters · filed 2026-02-25 | $1.21M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $564.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $441.00K 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |